ArticleTherapeutic advances in hematology2025

Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong.

Qiwen Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.